Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Liabilities and Shareholders Equity (2019 - 2025)

Historic Liabilities and Shareholders Equity for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to $6.4 million.

  • Volitionrx's Liabilities and Shareholders Equity fell 4914.23% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.1 million, marking a year-over-year decrease of 5477.7%. This contributed to the annual value of $9.4 million for FY2024, which is 6637.08% down from last year.
  • According to the latest figures from Q3 2025, Volitionrx's Liabilities and Shareholders Equity is $6.4 million, which was down 4914.23% from $8.7 million recorded in Q2 2025.
  • Over the past 5 years, Volitionrx's Liabilities and Shareholders Equity peaked at $35.2 million during Q2 2021, and registered a low of $6.4 million during Q3 2025.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $18.9 million (2022), whereas its average is $20.0 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 5277.63% in 2023, then plummeted by 6637.08% in 2024.
  • Quarter analysis of 5 years shows Volitionrx's Liabilities and Shareholders Equity stood at $27.5 million in 2021, then crashed by 33.45% to $18.3 million in 2022, then surged by 52.78% to $28.0 million in 2023, then tumbled by 66.37% to $9.4 million in 2024, then crashed by 31.39% to $6.4 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $6.4 million for Q3 2025, versus $8.7 million for Q2 2025 and $8.5 million for Q1 2025.